Our editorial approach
We collect, summarize, and contextualize information about treatment claims and safety practices. Our editorial process emphasizes primary sources and registries, peer-reviewed literature, official guidance where available, and transparent notes where evidence is thin. For example, we reference recognized registries and summaries of clinical trials when describing outcomes and safety considerations; we also explain when a claim exceeds the available data.
We organize material so readers can move from a concise safety checklist to deeper explanatory pieces. If you want to explore our site structure in context, our overview of services explains how we present assessments and resources on a practical basis: our description of services links to an outline of what we evaluate and why.
How we source and vet information
We prioritize official registries and peer-reviewed publications and aim to surface regulatory guidance when relevant. That includes citing public clinical registries and established scientific repositories to verify reported outcomes. To support claims about clinical practice standards we also consult authoritative summaries, for instance an explanatory entry on clinical trials methodology on Wikipedia (clinical trial overview) and guidance from major research universities when describing evidence appraisal (Harvard Health).
Editorial principles
- Independence: we do not accept clinical referrals or commercial sponsorship that would influence coverage.
- Evidence before claims: we flag uncertainty and avoid overstating outcomes.
- Safety transparency: practical safety practices and unanswered questions are highlighted for readers.
- Plain language: technical findings are translated for non-experts without losing nuance.
What we cover
Our coverage focuses on the intersection of treatment claims, patient safeguards, and evidence; pieces range from short safety checklists and summaries to more detailed evidence briefs. We do not provide medical or legal advice nor operate as a treatment provider. Readers seeking direct services should consult licensed medical professionals and verified clinic information rather than rely on our analysis alone.
Who this is for
This resource is intended for people researching options or supporting someone considering an intervention. If you are comparing care settings, you may find our synthesized safety checklist helpful; our services overview explains how we assess claims and what kinds of support material we produce to aid decision-making.
Signal Vein helps people assess claims, evidence, safety practices, and unanswered questions around ibogaine treatment at Ambio. It treats ibogaine as an investigational, medically intensive intervention rather than a proven cure.
Independent by design
We are an independent information resource, not a clinic, medical provider, or licensed treatment center. Our content is not medical or legal advice. For authoritative public health guidance, consult government resources such as the U.S. National Library of Medicine (NLM), which maintains clinical literature and registry links used in evidence verification.
We also weave practical external resources into our prose where they help validate a claim or explain a method; for example, some readers consult cost and logistical guides when preparing to compare options — an external resource summarizing international cost comparisons is one entry we link to when context is needed (international treatment cost guide).